DigestAI news desk

Cut through the AI noise.

Company

Arc Institute news

The latest Arc Institute news, : Stanford PhD uses generative AI to draft genetic blueprints for microscopic viruses.

The available coverage does not define the Arc Institute; instead it focuses on AI‑related topics. Recent stories discuss Anthropic’s Claude model being examined for potential bioweapon research and broader AI safety concerns, and a separate report on a virtual cell model from Westlake University predicting drugs for triple‑negative breast cancer.

2 stories mentioning Arc Institute since 23 September 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.

  1. Research new

    Stanford PhD uses generative AI to draft genetic blueprints for microscopic viruses

    Samuel King, a bioengineering PhD candidate at Stanford University and the Arc Institute, demonstrated a proof‑of‑concept in 2025 where a generative AI model suggested genetic sequences for tiny viruses. In a…

    1 source
    MIT Technology Review AI
  2. Policy & Regulation new

    Opinion: Radical Numerics warns biosecurity AI arms race may outpace defense

    In an interview with Latent Space, Eric Nguyen, co‑founder and CEO of Radical Numerics, argues that advances in genomic language models (GLMs) are turning bio‑security into an AI arms race. He notes that early models…

    1 source
    Latent Space

Questions about Arc Institute

What is the latest Arc Institute news?

As of 16 October 2026: Stanford PhD uses generative AI to draft genetic blueprints for microscopic viruses. Samuel King, a bioengineering PhD candidate at Stanford University and the Arc Institute, demonstrated a proof‑of‑concept in 2025 where a generative AI model suggested genetic sequences for tiny viruses.

What is Arc Institute?

The available coverage does not define the Arc Institute; instead it focuses on AI‑related topics. Recent stories discuss Anthropic’s Claude model being examined for potential bioweapon research and broader AI safety concerns, and a separate report on a virtual cell model from Westlake University predicting drugs for triple‑negative breast cancer.